Riskpilot← Back to searchSign inGet full accessLEKVEMOGATA 12 B AS
ASActiveOrg 812550802Lekvemogata 12B, 5700 VossRental and operating of own or leased real estate · NACE 6820Est. 20130 employees
Revenue 2025
NOK 324K
+18% vs 2024
EBITDA margin
88.7%
+18% vs 2024
Equity ratio
30.3%
Financial strength
Net profit 2025
NOK 80K
+174% vs 2024
| Revenue | NOK 324K | +18% |
| EBITDA | NOK 287K | +18% |
| Net profit | NOK 80K | +174% |
| Total assets | NOK 1,7M | -5% |
| Equity | NOK 511K | +19% |
| Employees | 0 | — |
Legal name
LEKVEMOGATA 12 B AS
Org number
812550802
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
8. oktober 2013
Share capital
NOK 400 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Kjøp, salg og drift av fast eiendom samt det som naturlig står i forbindelse med dette samt investeringer i andre selskaper.
Address
Lekvemogata 12B, 5700 Voss
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 265 | 265 | 265 | 275 | 324 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 233 | 237 | 233 | 244 | 287 |
| Depreciation & amort. | −101 | −101 | −101 | −101 | −101 |
| EBIT | 132 | 136 | 132 | 143 | 186 |
| Net financials | −97 | −82 | −110 | −105 | −83 |
| Profit before tax | 34 | 54 | 22 | 37 | 103 |
| Tax | −0 | −0 | 1 | 8 | 23 |
| Net profit | 34 | 54 | 22 | 29 | 80 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 051 | 1 971 | 1 887 | 1 777 | 1 690 |
| Equity | 326 | 380 | 402 | 431 | 511 |
| Long-term debt | 1 725 | 1 591 | 1 476 | 1 333 | 0 |
| Short-term debt | 0 | 0 | 10 | 12 | 33 |
| Total debt | 1 725 | 1 591 | 1 485 | 1 345 | 1 179 |
EBITDA margin
88.7%
This company
15.8%
Market median
+461% vs market
20212025
Equity ratio
30.3%
This company
38.2%
Market median
+21% vs market
20212025
Return on equity
15.7%
This company
18.4%
Market median
+15% vs market
20212025
Net profit margin
24.7%
This company
8.1%
Market median
+205% vs market
20212025
Asset turnover
0.19×
This company
1.12×
Market median
-83% vs market
20212025
Debt / equity
2.31×
This company
0.62×
Market median
-273% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SI Chief Executive Officer | Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2025 | |
| Chairman | 2013 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 60% | 60% | 2023 | |
| Individual | 15% | 15% | 2023 | |
| Individual | 12.5% | 12.5% | 2023 | |
| Individual | 12.5% | 12.5% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LEKVEMOGATA 12 B AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stig Ingvar Hernes | Chief Executive Officer | 0 companies |
| Robert Frode Gullbrå | Chairman | 0 companies |
| Gunnar Århus | Chairman | 0 companies |